Skip to main content
Press Release

Stamford Pharmacy to Pay $45,000 to Settle Allegations Under the Controlled Substances Act

For Immediate Release
U.S. Attorney's Office, District of Connecticut

Deirdre M. Daly, United States Attorney for the District of Connecticut, today announced that Stamford Pharmacy, located at 1055 High Ridge Road in Stamford, has entered into a civil settlement with the government to resolve allegations that it violated civil provisions of the Controlled Substances Act. Stamford Pharmacy has agreed to pay a total of $45,000.

The allegations against Stamford Pharmacy include claims that they failed to promptly file theft and loss reports of controlled substances with the DEA in at least 17 separate instances as required by law, and that they failed to keep current, complete, and accurate controlled substance records of each controlled substance purchased and dispensed.

Congress, with the passage of the Controlled Substances Act, took steps to create “a closed system” of distribution for controlled substances in which every facet of the handling of the substances, from their manufacture to their consumption by the ultimate user, was to be subject to intense governmental regulation. This mission was taken against the backdrop of trying to prevent the diversion and abuse of legitimate controlled substances while at the same time ensuring an adequate supply of those substances needed to meet the medical and scientific needs of the United States.

This investigation was conducted by investigators from the Drug Enforcement Administration’s Office of Diversion Control in Rocky Hill, and the State of Connecticut, Department of Consumer Protection, Drug Control Division. The prosecution was led by Assistant U.S. Attorney Alan M. Soloway.

Updated April 27, 2015